[CyberKnife®: new treatment option for uveal melanoma].

Background: CyberKnife® stereotactic radiosurgery is a new treatment option for uveal melanoma.
Objective: This review outlines the technique of robot-assisted CyberKnife® therapy, as well as the pros and cons in the treatment of uveal melanoma.
Methods: The study provides a PubMed literature review and own preliminary clinical experiences.
Results: CyberKnife® therapy for choroidal and ciliary body melanomas shows comparable results concerning local tumor control and overall survival matching those of conventional therapies. With only low complication rates, a high level of quality of life can be conserved by possible preservation of visual acuity as well as the ocular globe.
Conclusion: Stereotactic radiosurgery using CyberKnife® seems to be an efficient and safe therapeutic option for malignant melanomas affecting the choroid and ciliary body. Comparative studies with conventional radiation strategies are now a high priority.